Postoperative Care of the Liver-Transplant Patient

  • Philip A. Berry
  • Hector Vilca Melendez
  • Julia A. Wendon


Liver transplantation (LT) is performed to improve life expectancy and quality of life in patients with advanced chronic liver disease (CLD), and to save life in the context of acute liver failure (ALF). These two groups of patients differ significantly in terms of mean age, prior comorbidity, and degree of extra-hepatic organ dysfunction, requiring substantially different approaches to supportive care. Common aspects of care are those directed at the transplanted organ itself, with regard to monitoring and recognition of early dysfunction, initiation of immunosuppression, and management of surgical complications. Close liaison with the multidisciplinary team, which will include the intensivist, transplant surgeon, transplant hepatologist, anesthesiologist, and radiologist, is required.


Liver Transplantation Inferior Vena Cava Acute Liver Failure Acute Cellular Rejection Hepatic Artery Thrombosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Londoño MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006;130(4):1135–1143.PubMedCrossRefGoogle Scholar
  2. 2.
    Abbasoglu O, Goldstein RM, Vodapally MS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant. 1998;12(3):263–269.PubMedGoogle Scholar
  3. 3.
    Colle IO, Moreau R, Gondhino E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37(2):401–409.PubMedCrossRefGoogle Scholar
  4. 4.
    Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11(12):1581–1589.PubMedCrossRefGoogle Scholar
  5. 5.
    Reich DL, Wood RK, Emre S, et al. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2003;17(6):699–702.PubMedCrossRefGoogle Scholar
  6. 6.
    Sussman N, Kaza V, Barshes N, et al. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant. 2006;6:2177.PubMedCrossRefGoogle Scholar
  7. 7.
    Acosta F, Sansano T, Palenciano C, et al. Portopulmonary hypertension and liver transplantation: hemodynamic consequences at reperfusion. Transplant Proc. 2005;37(9):3865–3866.PubMedCrossRefGoogle Scholar
  8. 8.
    Acosta F, Sansano T, Palenciano CG, et al. Effects of dobutamine on right ventricular function and pulmonary circulation in pulmonary hypertension during liver transplantation. Transplant Proc. 2005;37(9):3869–3870.PubMedCrossRefGoogle Scholar
  9. 9.
    Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology. 2002;36(2):395–402.PubMedCrossRefGoogle Scholar
  10. 10.
    Wolf RF, Sluiter WJ, Ballast A, et al. Venous air embolism, preservation/reperfusion injury, and the presence of intravascular air collection in human donor livers: a retrospective clinical study. Transpl Int. 1995;8(3):201–206.PubMedCrossRefGoogle Scholar
  11. 11.
    Viana JS, Furtado E, Romero A, et al. Air embolism as a complication of venovenous bypass during liver transplant for diffuse hemangiomatosis. Transplant Proc. 2003;35(3):1128–1130.PubMedCrossRefGoogle Scholar
  12. 12.
    Singh N, Gayowski T, Wagener M, et al. Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation. 1999;67(8):1138–1144.PubMedCrossRefGoogle Scholar
  13. 13.
    Kotzampassi K, Paramythiotis D, Eleftheriadis E. Deterioration of visceral perfusion caused by intra-abdominal hypertension in pigs ventilated with positive end-expiratory pressure. Surg Today. 2000;30(11):987–992.PubMedCrossRefGoogle Scholar
  14. 14.
    Fujita Y. Effects of PEEP on splanchnic hemodynamics and blood volume. Acta Anaesthesiol Scand. 1993;37(4):427–431.PubMedCrossRefGoogle Scholar
  15. 15.
    Saner FH, Pavlakovic G, Gu Y, et al. Effects of positive end-expiratory pressure on systemic haemodynamics, with special interest to central venous and common iliac venous pressure in liver transplanted patients. Eur J Anaesthesiol. 2006;23(9):766–771.PubMedCrossRefGoogle Scholar
  16. 16.
    Junge G, Schewior LV, Kohler S, et al. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome. Transplant Proc. 2006;38(3):723–724.PubMedCrossRefGoogle Scholar
  17. 17.
    Whitta RK, Marshall C, Bates S, et al. Intraoperative mannitol does not prevent renal failure in orthotopic liver transplantation. Crit Care Resusc. 2001;3(2):75–80.PubMedGoogle Scholar
  18. 18.
    Biancofiore G, Bindi ML, Boldrini A, et al. Intraabdominal pressure in liver transplant recipients: incidence and clinical significance. Transplant Proc. 2004;36(3):547–549.PubMedCrossRefGoogle Scholar
  19. 19.
    Handschin AE, Weber M, Renner E, et al. Abdominal compartment syndrome after liver transplantation. Liver Transpl. 2005;11(1):98–100.PubMedCrossRefGoogle Scholar
  20. 20.
    Keays R, Potter D, O’Grady J, et al. Intracranial and cerebral perfusion pressure changes before, during and immediately after orthotopic liver transplantation for fulminant hepatic failure. Q J Med. 1991;79(289):425–433.PubMedGoogle Scholar
  21. 21.
    Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology. 2000;32(3):536–541.PubMedCrossRefGoogle Scholar
  22. 22.
    Ardizzone G, Arrigo A, Schellino MM, et al. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc. 2006;38(3):789–792.PubMedCrossRefGoogle Scholar
  23. 23.
    Singh N, Wagener M, Obman A, et al. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl. 2004;10(7):844–849.PubMedCrossRefGoogle Scholar
  24. 24.
    Cerutti E, Stratta C, Romagnoli R, et al. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl. 2006;12(8):1253–1259.PubMedCrossRefGoogle Scholar
  25. 25.
    Philpott-Howard J, Burroughs A, Fisher N, et al. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. J Antimicrob Chemother. 2003;52(6):993–1000.PubMedCrossRefGoogle Scholar
  26. 26.
    Echaniz-Quintana A, Pita-Fernández S, Otero-Ferreiro A, et al. Risk factors associated with invasive fungal infection in orthotopic liver transplantation. Med Clin (Barc). 2004;122(12):444–448.Google Scholar
  27. 27.
    Singh N, Gayowski T, Wagener MM, et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis. 1997;24(2):179–184.PubMedCrossRefGoogle Scholar
  28. 28.
    Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation. 1997;64(5):716–720.PubMedCrossRefGoogle Scholar
  29. 29.
    Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation – a randomized, double-blind trial. Am J Transplant. 2005;5(1): 125–130.PubMedCrossRefGoogle Scholar
  30. 30.
    Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32(4 Pt 1):734–739.PubMedCrossRefGoogle Scholar
  31. 31.
    Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16(4):389–402.PubMedCrossRefGoogle Scholar
  32. 32.
    Bzeizi KI, Jalan R, Plevris JN, et al. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg. 1997;3(2):137–148.PubMedCrossRefGoogle Scholar
  33. 33.
    Maring JK, Klompmaker IJ, Zwaveling JH, et al. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplant. 1997;11(5 Pt 1):373–379.PubMedGoogle Scholar
  34. 34.
    Fernandez-Merino FJ, Nuño-Garza J, López-Hervás P, et al. Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. Transplant Proc. 2003;35(5):1793–1794.PubMedCrossRefGoogle Scholar
  35. 35.
    Tucker ON, Heaton N. The “small for size” liver syndrome. Curr Opin Crit Care. 2005;11(2):150–155.PubMedCrossRefGoogle Scholar
  36. 36.
    Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006;30(8):986–993.PubMedCrossRefGoogle Scholar
  37. 37.
    Klein AS, Cofer JB, Pruett TL, et al. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology. 1996;111(3):710–715.PubMedCrossRefGoogle Scholar
  38. 38.
    Henley KS, Lucey MR, Normolle DP, et al. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology. 1995;21(2):366–372.PubMedGoogle Scholar
  39. 39.
    Thies JC, Teklote J, Clauer U, et al. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int. 1998;11(Suppl 1):S390–S392.PubMedGoogle Scholar
  40. 40.
    Manika A, Trinh T, Lagacé G, et al. N-acetylcysteine in pig liver transplantation from non-heart-beating donors. Transplantation. 1999;68(3):327–330.PubMedCrossRefGoogle Scholar
  41. 41.
    A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994;331(17):1110–1115.Google Scholar
  42. 42.
    Zhou J, Fan J, Wang JH, et al. Continuous transcatheter arterial thrombolysis for early hepatic artery thrombosis after liver transplantation. Transplant Proc. 2005;37(10):4426–4429.PubMedCrossRefGoogle Scholar
  43. 43.
    Figueras J, Busquets J, Dominguez J, et al. Intra-arterial thrombolysis in the treatment of acute hepatic artery thrombosis after liver transplantation. Transplantation. 1995;59(9):1356–1357.PubMedGoogle Scholar
  44. 44.
    Rossleigh MA, McCaughan GW, Gallagher ND, et al. The role of nuclear medicine in liver transplantation. Med J Aust. 1988;148(11):561–563.PubMedGoogle Scholar
  45. 45.
    Faenza S, Ravaglia MS, Cimatti M, et al. Analysis of the causal factors of prolonged mechanical ventilation after orthotopic liver transplant. Transplant Proc. 2006;38(4):1131–1134.PubMedCrossRefGoogle Scholar
  46. 46.
    Gurakar A, Hassanein T, Van Thiel DH. Right diaphragmatic paralysis following orthotopic liver transplantation. J Okla State Med Assoc. 1995;88(4):149–153.PubMedGoogle Scholar
  47. 47.
    Singh N, Gayowski T, Wagener MM. Intensive care unit management in liver transplant recipients: beneficial effect on survival and preservation of quality of life. Clin Transplant. 1997;11(2):113–120.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Philip A. Berry
    • 1
  • Hector Vilca Melendez
    • 1
  • Julia A. Wendon
    • 1
  1. 1.Institute of Liver Studies, King’s College HospitalKing’s College LondonLondonUK

Personalised recommendations